Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
Cillóniz, C.; de la Calle, C.; Dominedò, C.; García-Vidal, C.; Cardozo, C.; Gabarrús, A.; Marco, F.; Torres, A.; Soriano, A. Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia. J. Clin. Med. 2019, 8, 1150. https://doi.org/10.3390/jcm8081150
Cillóniz C, de la Calle C, Dominedò C, García-Vidal C, Cardozo C, Gabarrús A, Marco F, Torres A, Soriano A. Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia. Journal of Clinical Medicine. 2019; 8(8):1150. https://doi.org/10.3390/jcm8081150
Chicago/Turabian StyleCillóniz, Catia, Cristina de la Calle, Cristina Dominedò, Carolina García-Vidal, Celia Cardozo, Albert Gabarrús, Francesc Marco, Antoni Torres, and Alex Soriano. 2019. "Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia" Journal of Clinical Medicine 8, no. 8: 1150. https://doi.org/10.3390/jcm8081150


